Cancer diagnostics company raises $2.5m seed funding:
This article was originally published in Clinica
VC firm Kodiak Venture Partners has invested $2.5m in Cambridge Devices, a Cambridge, Massachusetts start-up focused on technologies for improving cancer diagnostics. The company, established in 2004, is developing two medical devices; the tissue identification probe is designed to enable more accurate diagnosis of breast cancer, while the fluorescence polarisation imaging system is to help doctors excise skin cancers more effectively and reduce recurrence of cancerous cells.
You may also be interested in...
Can shaving ever be “friction free”? Not according to Procter & Gamble, which challenged in a complaint to the UK Advertising Standards Authority a claim made by a British cosmetics firm FFS that it provided a “friction free” shaving experience for women via its subscription razor service.
Work has started on UK-only regulations for the medtech and medicines sectors, to ensure that the regulatory framework not only functions but can also react swiftly to needs after the UK leaves the EU. This article is part two of two.